Given the complementary roles of ADRA2A and SLC6A2 in norepinephrine regulation, the combined analysis of these two polymorphisms may offer insight into the genetic mechanisms underlying ADHD and help clarify variability in cognitive performance and treatment response. The gene discussed is ADRA2A; the disease is attention deficit-hyperactivity disorder.